Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Disorders”

536 trials

Showing 20 of 536 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT01928615
What this trial is testing

Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2
Not applicableStudy completedNCT00001885
What this trial is testing

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Who this might be right for
HealthyPulmonary FibrosisRheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI) 400
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Early research (Phase 1)Study completedNCT01166555
What this trial is testing

Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers

Who this might be right for
Healthy
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT02067910
What this trial is testing

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
University Medical Center Groningen 80
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Large-scale testing (Phase 3)Study completedNCT01964391
What this trial is testing

Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 174
Early research (Phase 1)Study completedNCT02738970
What this trial is testing

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 88
Not applicableStudy completedNCT01521884
What this trial is testing

Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy

Who this might be right for
Rheumatoid Arthritis
Pfizer 62
Large-scale testing (Phase 3)Study completedNCT01386658
What this trial is testing

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 32
Large-scale testing (Phase 3)UnknownNCT02830685
What this trial is testing

Pre-pectoral Breast Reconstruction PART 1

Who this might be right for
Breast Cancer
Guy's and St Thomas' NHS Foundation Trust 131
Testing effectiveness (Phase 2)Ended earlyNCT01059448
What this trial is testing

Safety and Efficacy of AMG 827 in Subjects With RA

Who this might be right for
Rheumatoid Arthritis
Amgen 211
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101134
What this trial is testing

Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)UnknownNCT00829192
What this trial is testing

Phase II AK Study in Organ Transplant Patients

Who this might be right for
Actinic KeratosesCarcinoma, Squamous CellOrgan Transplant Recipients
Clinuvel Pharmaceuticals Limited 200
Testing effectiveness (Phase 2)Study completedNCT00837811
What this trial is testing

An Open Label Extension Study in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 182
Testing effectiveness (Phase 2)Active Not RecruitingNCT06444451
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Sanofi 166
Large-scale testing (Phase 3)Study completedNCT04711902
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 41
Early research (Phase 1)Study completedNCT04246762
What this trial is testing

Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 17
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation